Allergy Therapeutics PLC Stock
Price
Target price
€0.079
€0.079
9.720%
0.007
9.720%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Allergy Therapeutics PLC Stock
Allergy Therapeutics PLC dominated the market today, gaining €0.007 (9.720%).
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | 9.720% | 4.636% | 7.483% | 36.207% | 15.328% | -65.948% | - |
| Cellectar BioSciences Inc. | -8.520% | 40.351% | 49.533% | -88.489% | 2.564% | -91.990% | - |
| Beximco Pharmaceuticals Ltd. GDR | 2.420% | -7.826% | 6.000% | 0.952% | 2.415% | -53.149% | -6.195% |
| SELLAS Life Sciences Group Inc | 0.140% | -6.125% | -6.000% | 8.462% | 49.841% | -48.333% | -53.511% |
News
AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
[content-module:CompanyOverview|NYSE:T]
Investor focus on AT&T (NYSE: T) is starting to sharpen, with the company’s stock price making a healthy upward move of nearly 50% over the past year as of
Here's How Many Shares of AT&T You Must Own to Make $5,000 in Annual Dividend Income
More than 100 million Americans use AT&T's (NYSE: T) products and services. So do nearly 2.5 million businesses. How many investors rely on A&T's stock to generate reliable dividend income? I don't
AT&T Stock Nears 52-Week High, But Is It Too Late to Buy?
AT&T (NYSE: T) is making waves again, climbing toward its 52-week high and locking in billion-dollar fiber deals. With rising cash flow, solid dividends, and 5G ambitions, is this legacy telecom